Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Dec;71(12):9844–9848. doi: 10.1128/jvi.71.12.9844-9848.1997

A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.

D R Shafren 1, D T Williams 1, R D Barry 1
PMCID: PMC230302  PMID: 9371658

Abstract

The composition of the cellular receptor complex for coxsackievirus B3 (CVB3) has been an area of much contention for the last 30 years. Recently, two individual components of a putative CVB3 cellular receptor complex have been identified as (i) decay-accelerating factor (DAF) and (ii) the coxsackievirus-adenovirus receptor protein (CAR). The present study elucidates the individual roles of DAF and CAR in cell entry of CVB3 Nancy. First, we confirm that the DAF-binding phenotype of CVB3 correlates to the presence of key amino acids located in the viral capsid protein, VP2. Second, using antibody blockade, we show that complete protection of permissive cells from infection by high input multiplicities of CVB3 requires a combination of both anti-DAF and anti-CAR antibodies. Finally, it is shown that expression of the CAR protein on the surface of nonpermissive DAF-expressing RD cells renders them highly susceptible to CVB3-mediated lytic infection. Therefore, although the majority of CVB3 Nancy attaches to the cell via DAF, only virus directly interacting with the CAR protein mediates lytic infection. The role of DAF in CVB3 cell infection may be analogous to that recently described for coxsackievirus A21 (D. R. Shafren, D. J. Dorahy, R. A. Ingham, G. F. Burns, and R. D. Barry, J. Virol. 71:4736-4743, 1997), in that DAF may act as a CVB3 sequestration site, enhancing viral presentation to the functional CAR protein.

Full Text

The Full Text of this article is available as a PDF (573.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergelson J. M., Chan M., Solomon K. R., St John N. F., Lin H., Finberg R. W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245–6248. doi: 10.1073/pnas.91.13.6245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997 Feb 28;275(5304):1320–1323. doi: 10.1126/science.275.5304.1320. [DOI] [PubMed] [Google Scholar]
  3. Bergelson J. M., Modlin J. F., Wieland-Alter W., Cunningham J. A., Crowell R. L., Finberg R. W. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis. 1997 Mar;175(3):697–700. doi: 10.1093/infdis/175.3.697. [DOI] [PubMed] [Google Scholar]
  4. Bergelson J. M., Mohanty J. G., Crowell R. L., St John N. F., Lublin D. M., Finberg R. W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol. 1995 Mar;69(3):1903–1906. doi: 10.1128/jvi.69.3.1903-1906.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casasnovas J. M., Springer T. A. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J Virol. 1994 Sep;68(9):5882–5889. doi: 10.1128/jvi.68.9.5882-5889.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clarkson N. A., Kaufman R., Lublin D. M., Ward T., Pipkin P. A., Minor P. D., Evans D. J., Almond J. W. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J Virol. 1995 Sep;69(9):5497–5501. doi: 10.1128/jvi.69.9.5497-5501.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coyne K. E., Hall S. E., Thompson S., Arce M. A., Kinoshita T., Fujita T., Anstee D. J., Rosse W., Lublin D. M. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol. 1992 Nov 1;149(9):2906–2913. [PubMed] [Google Scholar]
  8. Crowell R. L., Field A. K., Schleif W. A., Long W. L., Colonno R. J., Mapoles J. E., Emini E. A. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol. 1986 Feb;57(2):438–445. doi: 10.1128/jvi.57.2.438-445.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crowell R. L., Philipson L. Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virol. 1971 Oct;8(4):509–515. doi: 10.1128/jvi.8.4.509-515.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gómez Yafal A., Kaplan G., Racaniello V. R., Hogle J. M. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology. 1993 Nov;197(1):501–505. doi: 10.1006/viro.1993.1621. [DOI] [PubMed] [Google Scholar]
  11. Hsu K. H., Lonberg-Holm K., Alstein B., Crowell R. L. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol. 1988 May;62(5):1647–1652. doi: 10.1128/jvi.62.5.1647-1652.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kinoshita T., Medof M. E., Silber R., Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 1985 Jul 1;162(1):75–92. doi: 10.1084/jem.162.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klump W. M., Bergmann I., Müller B. C., Ameis D., Kandolf R. Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol. 1990 Apr;64(4):1573–1583. doi: 10.1128/jvi.64.4.1573-1583.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Knowlton K. U., Jeon E. S., Berkley N., Wessely R., Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol. 1996 Nov;70(11):7811–7818. doi: 10.1128/jvi.70.11.7811-7818.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lindberg A. M., Crowell R. L., Zell R., Kandolf R., Pettersson U. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 1992 Jul;24(2):187–196. doi: 10.1016/0168-1702(92)90006-u. [DOI] [PubMed] [Google Scholar]
  16. Lindberg A. M., Stålhandske P. O., Pettersson U. Genome of coxsackievirus B3. Virology. 1987 Jan;156(1):50–63. doi: 10.1016/0042-6822(87)90435-1. [DOI] [PubMed] [Google Scholar]
  17. Lonberg-Holm K., Crowell R. L., Philipson L. Unrelated animal viruses share receptors. Nature. 1976 Feb 26;259(5545):679–681. doi: 10.1038/259679a0. [DOI] [PubMed] [Google Scholar]
  18. Muckelbauer J. K., Kremer M., Minor I., Diana G., Dutko F. J., Groarke J., Pevear D. C., Rossmann M. G. The structure of coxsackievirus B3 at 3.5 A resolution. Structure. 1995 Jul 15;3(7):653–667. doi: 10.1016/s0969-2126(01)00201-5. [DOI] [PubMed] [Google Scholar]
  19. Nicholson-Weller A., Wang C. E. Structure and function of decay accelerating factor CD55. J Lab Clin Med. 1994 Apr;123(4):485–491. [PubMed] [Google Scholar]
  20. Reagan K. J., Goldberg B., Crowell R. L. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol. 1984 Mar;49(3):635–640. doi: 10.1128/jvi.49.3.635-640.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schmidt N. J., Ho H. H., Lennette E. H. Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol. 1975 Sep;2(3):183–185. doi: 10.1128/jcm.2.3.183-185.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shafren D. R., Bates R. C., Agrez M. V., Herd R. L., Burns G. F., Barry R. D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol. 1995 Jun;69(6):3873–3877. doi: 10.1128/jvi.69.6.3873-3877.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shafren D. R., Dorahy D. J., Greive S. J., Burns G. F., Barry R. D. Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by coxsackievirus A21. J Virol. 1997 Jan;71(1):785–789. doi: 10.1128/jvi.71.1.785-789.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shafren D. R., Dorahy D. J., Ingham R. A., Burns G. F., Barry R. D. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol. 1997 Jun;71(6):4736–4743. doi: 10.1128/jvi.71.6.4736-4743.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tomko R. P., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352–3356. doi: 10.1073/pnas.94.7.3352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vuorinen T., Vainionpä R., Vanharanta R., Hyypiä T. Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection. J Virol. 1996 Dec;70(12):9018–9023. doi: 10.1128/jvi.70.12.9018-9023.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ward T., Pipkin P. A., Clarkson N. A., Stone D. M., Minor P. D., Almond J. W. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 1994 Nov 1;13(21):5070–5074. doi: 10.1002/j.1460-2075.1994.tb06836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de Verdugo U. R., Selinka H. C., Huber M., Kramer B., Kellermann J., Hofschneider P. H., Kandolf R. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol. 1995 Nov;69(11):6751–6757. doi: 10.1128/jvi.69.11.6751-6757.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES